Summary by Moomoo AI
CLOVER BIOPHARMACEUTICAL CO., LTD. (“CLOVER BIO-B”) WILL HOLD A BOARD MEETING ON TUESDAY, MARCH 26, 2024. THE MAIN AGENDA IS TO CONSIDER AND APPROVE THE ANNUAL RESULTS REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 AND ITS PUBLICATION. The meeting will also assess whether a final dividend will be paid. The members of the Board of Directors include Executive Directors Dr. Leung Pang and Mr. Liang Guo, Non-Executive Directors Dr. Wang Xiaodong, Dr. Donna Marie AMBROSINO, Dr. Ralf Leo CLEMENS, and Independent Non-Executive Directors Dr. Wu Xiaobin, Mr. Liao Chou, Mr. Jeffrey FARROW and Mr. Thomas LEGGETT.
